Insights

Key Personnel Update BioAge recently appointed Jean-Pierre Garnier, former CEO of GlaxoSmithKline, as Chair of the Board of Directors, potentially indicating an increased focus on strategic partnerships and industry connections.

Successful IPO Securing $200 million through a recent IPO signifies strong investor interest in BioAge's focus on developing therapies for obesity and diabetes, creating an opportunity to leverage this financial backing for accelerated growth and research.

Clinical-Stage Biotech Focus Given BioAge's specialization in developing therapies for metabolic diseases, particularly in the advanced stage of clinical trials, there is a potential for partnerships with healthcare providers looking to offer novel treatments to patients.

Strategic Funding Raising $170 million in funding from Sofinnova Partners reflects investor confidence in BioAge's research and development pipeline, presenting an opportunity to engage with investment firms interested in biotech opportunities.

Market Opportunity Being part of a competitive landscape with companies like Longenesis, Insilico Medicine, and AiCure indicates a growing market for innovative biotech solutions. BioAge's focus on obesity and metabolic diseases positions them as a valuable player in this evolving market.

BioAge Labs Tech Stack

BioAge Labs uses 8 technology products and services including Google Analytics, Cloudflare CDN, Grakn, and more. Explore BioAge Labs's tech stack below.

  • Google Analytics
    Analytics
  • Cloudflare CDN
    Content Delivery Network
  • Grakn
    Database
  • PWA
    Miscellaneous
  • Open Graph
    Miscellaneous
  • Node.js
    Programming Languages
  • three.js
    Programming Languages
  • Gephi
    Visualisation Software

BioAge Labs's Email Address Formats

BioAge Labs uses at least 1 format(s):
BioAge Labs Email FormatsExamplePercentage
First@bioagelabs.comJohn@bioagelabs.com
78%
First.Last@bioagelabs.comJohn.Doe@bioagelabs.com
17%
FirstL@bioagelabs.comJohnD@bioagelabs.com
4%
Last@bioagelabs.comDoe@bioagelabs.com
1%

Frequently Asked Questions

Where is BioAge Labs's headquarters located?

Minus sign iconPlus sign icon
BioAge Labs's main headquarters is located at 1445A S 50th St Richmond, CA 94804 US. The company has employees across 4 continents, including North AmericaEuropeSouth America.

What is BioAge Labs's stock symbol?

Minus sign iconPlus sign icon
BioAge Labs is a publicly traded company; the company's stock symbol is BIOA.

What is BioAge Labs's official website and social media links?

Minus sign iconPlus sign icon
BioAge Labs's official website is bioagelabs.com and has social profiles on LinkedIn.

How much revenue does BioAge Labs generate?

Minus sign iconPlus sign icon
As of December 2024, BioAge Labs's annual revenue reached $15M.

What is BioAge Labs's SIC code NAICS code?

Minus sign iconPlus sign icon
BioAge Labs's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does BioAge Labs have currently?

Minus sign iconPlus sign icon
As of December 2024, BioAge Labs has approximately 93 employees across 4 continents, including North AmericaEuropeSouth America. Key team members include Chief Business Officer And Head Of Brain Aging: P. L.Chief Strategy Officer: B. S.Chief Development Officer: A. N.. Explore BioAge Labs's employee directory with LeadIQ.

What industry does BioAge Labs belong to?

Minus sign iconPlus sign icon
BioAge Labs operates in the Biotechnology Research industry.

What technology does BioAge Labs use?

Minus sign iconPlus sign icon
BioAge Labs's tech stack includes Google AnalyticsCloudflare CDNGraknPWAOpen GraphNode.jsthree.jsGephi.

What is BioAge Labs's email format?

Minus sign iconPlus sign icon
BioAge Labs's email format typically follows the pattern of . Find more BioAge Labs email formats with LeadIQ.

How much funding has BioAge Labs raised to date?

Minus sign iconPlus sign icon
As of December 2024, BioAge Labs has raised $170M in funding. The last funding round occurred on Feb 13, 2024 for $170M.

When was BioAge Labs founded?

Minus sign iconPlus sign icon
BioAge Labs was founded in 2015.
BioAge Labs

BioAge Labs

Biotechnology ResearchCalifornia, United States51-200 Employees

BioAge is a clinical-stage biotechnology company that is harnessing the biology of human aging to develop novel targets and therapies for metabolic diseases. Our proprietary platform, which encompasses >65M molecular measurements spanning 45+ years of human aging, unlocks a universe of novel biological insights and druggable mechanisms for age-related disease. The company’s lead program, azelaprag, is a potential first-in-class oral APJ agonist entering Phase 2 trials in combination with tirzepatide for the treatment of obesity in older adults. Azelaprag has the potential as an oral regimen to amplify weight loss and improve body composition in patients on obesity therapy with incretin drugs. BioAge’s preclinical programs address key pathways in metabolic aging, based on novel insights from its discovery platform built on human longevity data. 


BioAge offers a comprehensive compensation package, comprehensive health and wellness benefits (medical, dental, and vision insurance), childcare and fertility benefits, and a 401(k) retirement savings plan with matched employer contributions. We pride ourselves on giving employees many opportunities for career development, including a generous annual budget for continued learning and dedication to training and skill development.

At BioAge, everyone matters, and we embrace diversity and differences while we learn from each other. We are an equal opportunity employer. BioAge prohibits discrimination and harassment of any type and affords equal employment opportunities to employees and applicants without regard to race, color, religion, sex, national origin, disability status, protected veteran status, or any other characteristic protected by law. BioAge conforms to the spirit as well as the letter of all applicable laws and regulations.

Section iconCompany Overview

Headquarters
1445A S 50th St Richmond, CA 94804 US
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
BIOA
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2015
Employees
51-200

Section iconFunding & Financials

  • $170M

    BioAge Labs has raised a total of $170M of funding over 5 rounds. Their latest funding round was raised on Feb 13, 2024 in the amount of $170M.

  • $10M$50M

    BioAge Labs's revenue is in the range of $10M$50M

Section iconFunding & Financials

  • $170M

    BioAge Labs has raised a total of $170M of funding over 5 rounds. Their latest funding round was raised on Feb 13, 2024 in the amount of $170M.

  • $10M$50M

    BioAge Labs's revenue is in the range of $10M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.